Dr. Eran Perlson

Tel Aviv University and Hadassah: Changes to Specific MicroRNA Involved in Development of Lou Gehrig’s Disease

A new Tel Aviv University study identifies a previously unknown mechanism involved in the development of Lou Gehrig’s disease, or amyotrophic lateral sclerosis (ALS)....

Read more

Kadimastem: Hadassah approvals IRB for conducting a clinical trial in ALS Patients

Israeli biotechnology company Kadimastem has received approval from the IRB (Helsinki Committee) of the Hadassah Ein Kerem Hospital for the phase I/IIa clinical trial...

Read more

Highly Promising Data From ALS Clinical Trial Conducted By Hadassah and Brainstorm (Israel)

A new ALS treatment utilizing a stem cell infusion protocol performed at Hadassah Medical Organization (HMO) and developed by the US/Israeli biotech company BrainStorm...

Read more

Israël Science Info